COronary Re-engageMent aFter randOm NavitoR alignmenT (COMFORT STUDY)

Sponsor
Niguarda Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05779787
Collaborator
(none)
100
1
14.9
6.7

Study Details

Study Description

Brief Summary

Whereas PCI before TAVR was previously recommended despite its uncertain prognostic role, recent data underline the possibility of a postponed coronary intervention using a commissural alignment technique. This approach allows easy coronary re-engagement through the valve stent frame with a trade off paid of procedure complexity.

Considering the prevalence of coronary artery disease (CAD) and the increasing percentage of younger patients treated with TAVI, investigate whether a simpler procedure with random implantation of Navitor valve is not inferior in terms of coronary re-access, is required The key point of the project will be the evaluation of the feasibility of coronary re-engagement after a Navitor valve randomly implanted.

Condition or Disease Intervention/Treatment Phase
  • Procedure: TAVR Aligned
  • Procedure: TAVR Random

Detailed Description

Transcatheter Aortic Valve Implantation (TAVI) is recommended by European and American guidelines to treat patients with aortic stenosis regardless of procedural risk (1, 2). In the last decades the increasing percentage of younger patients treated with TAVI, reflect the extensive indications in lower risk setting, highlighting the importance of easy coronary re-engagement after valve implantation. Considering the prevalence and the progression of a pre-existing coronary artery disease (CAD), the timing of coronary intervention should be accurate selected (3) addressing the percentage of unplanned percutaneous coronary intervention (PCI) after TAVI (4). In fact, while PCI before TAVR was previously recommend despite the uncertain prognostic role (5), recent data remarks the possibility of a postponed coronary intervention using a commissural alignment technique (6) that allows a predictable stent frame position in the sinus of Valsalva (7). Moreover, following the emerging concept of easy re-access, only a few types of prostheses have been shown to have an high degree of stent position predictability after implantation, leading to a limited option in terms of prosthesis choice. Furthermore, to achieve the best results with commissural alignment technique, accurate procedure planning and operator's expertise are required in order to properly manage the valve specific orientation in the aorta with consequent increase in time, radiation and procedure complexity.

However, geometry of the stent frame (height and size) and the anatomical characteristics of patients have to be enlisted as contributory factors to difficult coronary re-engagement and need to be evaluate in order to establish the feasibility of the re-access after TAVR.

The investigators' findings could provide data regarding the non-inferiority rate of coronary cannulation after a simpler procedure with Navitor implantation without alignment technique. Due to these results, the valves portfolio available in patients with coronary artery disease that needed PCI after TAVR, could be larger and various allowing the best protheses choice according to the patient's anatomy and operator's expertise. Finally, knowing the predictors of difficult re-engagement for both types of valves, regardless of implantation technique, could be interesting for an even more valve tailored approach.

The purpose of this study is to investigate the feasibility of coronary re-engagement after randomly (not aligned) Navitor implantation, as already perform in current clinical practice, due to a lower predictable orientation of this type of valve.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
COronary Re-EngageMent aFter RandOm NavitoR Alignment (COMFORT STUDY)
Actual Study Start Date :
Feb 15, 2023
Anticipated Primary Completion Date :
Feb 15, 2024
Anticipated Study Completion Date :
May 15, 2024

Arms and Interventions

Arm Intervention/Treatment
TAVR performed with commissural alignment technique (Aligned Group)

Patients with severe aortic stenosis undergoing TAVR procedure performed with commissural alignment technique. We consider in this groups only the Accurate and Accurate Neo 2 Valve which are the first choice due to the best stent frames position predictability with this technique

Procedure: TAVR Aligned
Investigate the feasibility of coronary re-engagement after commissural alignment technique in terms of success rate (%) and procedure complexity taking into account radiations, time and contrast used.

Procedure: TAVR Random
TAVR Random Feasibility comparison of coronary re-engagement between the randomly implanted Navitor valve (unaligned) and the others implanted with the commissural alignment technique in terms of success rate (%) and complexity of the procedure, taking into account radiation, time and contrast used

TAVR performed with random implantation of Navitor valve (Random Group)

Patients with severe aortic stenosis undergoing TAVR procedure performed with random implantation of Navitor Valve

Procedure: TAVR Aligned
Investigate the feasibility of coronary re-engagement after commissural alignment technique in terms of success rate (%) and procedure complexity taking into account radiations, time and contrast used.

Procedure: TAVR Random
TAVR Random Feasibility comparison of coronary re-engagement between the randomly implanted Navitor valve (unaligned) and the others implanted with the commissural alignment technique in terms of success rate (%) and complexity of the procedure, taking into account radiation, time and contrast used

Outcome Measures

Primary Outcome Measures

  1. Coronary re-access after TAVR procedure [During procedure]

    Re-engagement of LMCA and RCA after valve implantation is defined as selective cannulation and subsequent selective angiography. All others type of re-engagement will be classify as "non selective". We will stratify also the modality of re-cannulation in relation to the position of the valves' stent struts as "above", "across" and "behind".

Secondary Outcome Measures

  1. Total Implant Time [During procedure]

    Total time required for valve implantation. We count the time from the alignment in the aorta to the end of valve opening (Alignment Fluoroscopy time + Implantation Fluoroscopy time).

  2. Total Implant Fluoroscopy Time [During procedure]

    Total Fluoroscopy time required for valve implantation. We count the time from the alignment in the aorta to the end of valve opening (Alignment time + Implantation time).

  3. Total Implant Radiations [During procedure]

    Total Radiations required for valve implantation. We count the radiations used from the alignment in the aorta to the end of valve opening (Alignment time + Implantation time).

  4. Total Implant Contrast [During procedure]

    Total Contrast required for valve implantation

  5. Alignment Radiation [During procedure]

    Radiation required for commissural alignment

  6. Alignment Fluoroscopy Time [During procedure]

    Fluoroscopy time required for commissural alignment

  7. Implant Radiation [During procedure]

    Radiation required for valve implantation

  8. Implant Fluoroscopy Time [During procedure]

    Fluoroscopy time required for valve implantation

  9. Implant Contrast [During procedure]

    Contrast required for valve implantation

  10. Re-Engagement Radiation [During procedure]

    Radiation required for re-engagement

  11. Re-Engagement Fluoroscopy Time [During procedure]

    Fluoroscopy time required for coronary re-engagement

  12. Re-Engagement Contrast used [During procedure]

    Contrast required for coronary re-engagement

  13. Re-Engagement Time [During procedure]

    Time required for coronary re-engagement

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Patients to be included in this registry should have all the following criteria:
  1. Severe, symptomatic aortic stenosis with an indication to TAVI

Exclusion criteria and definition

Patients excluded in this registry should have all the following criteria:
  1. Valve in Valve procedure

  2. Hemodynamical instability

  3. TAVR performed from other access (not femoral)

  4. No-CT Planned TAVR

  5. TAVR performed with Chimney Technique

Contacts and Locations

Locations

Site City State Country Postal Code
1 ASST GOM Niguarda MIlano Lombardia Italy 20162

Sponsors and Collaborators

  • Niguarda Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Niguarda Hospital
ClinicalTrials.gov Identifier:
NCT05779787
Other Study ID Numbers:
  • D001024
First Posted:
Mar 22, 2023
Last Update Posted:
Mar 22, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 22, 2023